Physician profile
Kelsey Capron
NPI 1427541259
$1,507.62
in general payments reported to CMS, 2019-2025
17 companies · $718 in 2025
The $718 reported for 2025 was more than what 80% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $21.35 · 2022: $25.64 · 2023: $357 · 2024: $386 · 2025: $718.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,460.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $299.49 | 2023-2025 | Qulipta, Rinvoq, Vraylar |
| Novo Nordisk INC | $212.40 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $171.40 | 2024-2025 | Airsupra |
| Stryker Corporation | $168.73 | 2025 | Aequalis Ascend Flex |
| Pfizer INC. | $148.29 | 2025 | |
| Lilly USA, LLC | $143.24 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $74.05 | 2023-2025 | Trelegy Ellipta |
| Mylan Specialty L.P. | $58.44 | 2024 | Yupelri |
| Bayer Healthcare Pharmaceuticals INC. | $39.51 | 2024-2025 | |
| Organon LLC | $31.52 | 2023 | Nexplanon, Jada System |
| Amgen INC. | $29.53 | 2023-2025 | Prolia, Evenity, Repatha |
| Sanofi-Aventis U.S. LLC | $27.84 | 2025 | |
| Merck Sharp & Dohme LLC | $25.72 | 2025 | Capvaxive, Rotateq, Vaxneuvance |
| Biohaven Pharmaceutical Holding Company LTD. | $25.64 | 2022 | |
| Medical Device Business Services, INC. | $21.35 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $15.56 | 2023 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.91 | 2023 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelsey Capron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.